Caricamento...
Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...
Salvato in:
| Pubblicato in: | Kidney Med |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380391/ https://ncbi.nlm.nih.gov/pubmed/32734188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2019.03.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|